The IPO Buzz: Anteris (AVR) Prices NASDAQ Uplist Deal at $6 – Below Reference Price – & Raises $88.8 Million
Australian transcatheter heart valve developer Anteris Technologies Global (AVR) priced its NASDAQ uplisting/public offering at $6.00 – below its $6.78 reference price – and sold 14.8 million shares – the number of shares in the prospectus – to raise $88.8 million on Thursday night, Dec. 12, 2024. The $6.00 IPO price gave Anteris Technologies Global […]
December 12, 2024 Read More